|
KMID : 0620920170490040015
|
|
Experimental & Molecular Medicine
2017 Volume.49 No. 4 p.15 ~ p.15
|
|
|
Inhibition of glutathione metabolism attenuates esophageal cancer progression
|
|
Peng Liang
Linghu Ruixia
Chen De Meng
Yang Jing
Kou Xiao Xue
Hu Yi
Wang Xiang Zhen
Jiang Yi Zhou
Yang Jun Lan
|
|
|
Abstract
|
|
|
|
Esophageal squamous cell carcinoma (ESCC) is a deadly malignancy with regard to mortality and prognosis, and the 5-year survival rate for all patients diagnosed with ESCC remains poor. A better understanding of the biological mechanisms of ESCC tumorigenesis and progression is of great importance to improve treatment of this disease. In this study, we demonstrated that the glutathione metabolism pathway is highly enriched in ESCC cells compared with normal esophageal epithelial cells in an in vivo mouse model. In addition, treatment with L-buthionine-sulfoximine (BSO) to deplete glutathione decreased the ESCC tumor burden in mice, thus demonstrating the critical role of glutathione metabolism in ESCC progression. BSO treatment also led to decreased cell proliferation and activation of cell apoptosis in ESCC. Finally, BSO treatment blocked NF-kB pathway activation in ESCC. Our study reveals a new pathway that regulates ESCC progression and suggests that inhibition of glutathione metabolism may be a potential strategy for ESCC treatment.
|
|
|
KEYWORD
|
|
|
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
    
|